Dr Reddys trades flat despite announcing launch of Ertapenem in US market
Dr Reddys trades flat despite announcing launch of Ertapenem in US market

Dr Reddys trades flat despite announcing launch of Ertapenem in US market

Abhinav Lahoti Article rating: 4.0

Dr Reddy’s Laboratories Limited along with its subsidiaries today announced the launch of Ertapenem injection, which is a therapeutic equivalent generic version of Invanz (Ertapenem injection). The company received approval from US Food & Drug Administration (USFDA).

Zydus Cadila to sell animal health business to an asset management-led consortium
Zydus Cadila to sell animal health business to an asset management-led consortium

Zydus Cadila to sell animal health business to an asset management-led consortium

Shruti Dahiwal Article rating: 4.5

Cadila Healthcare Ltd, a global pharmaceutical company, announced today that its wholly-owned subsidiary, Zydus Animal Health & Investments Limited (ZAHL) has entered into a business transfer agreement (BTA) to sell & transfer its animal healthcare established markets undertaking (Zydus AH) to a consortium, which is led by Multiples Alternate Asset Management.

Suumaya Industries announces foray into agri-trading business
Suumaya Industries announces foray into agri-trading business

Suumaya Industries announces foray into agri-trading business

Shruti Dahiwal Article rating: 4.4

Suumaya Industries Ltd, a domestic company, which is engaged in the business of garment manufacturing for women, announced this morning that it has forayed into agri-trading business during March quarter of FY21.  

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 3.6

The market opened in red on May 12, 2021, overall volumes in futures & options currently stand at 4,62,06,497 contracts with a turnover of Rs. 42,73,308.97 crore.

Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

Ganesh Pawar Article rating: 3.3

The market opened in red on May 12, 2021, overall volumes in futures & options currently stand at 4,62,06,497 contracts with a turnover of Rs. 42,73,308.97 crore.

RSS
First18801881188218831885188718881889Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR